FDA — authorised 23 February 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: approved
🇺🇸 Farydak in United States
FDA authorised Farydak on 23 February 2015
Marketing authorisation
Farydak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Farydak approved in United States?
Yes. FDA authorised it on 23 February 2015.
Who is the marketing authorisation holder for Farydak in United States?
NOVARTIS PHARMS CORP holds the US marketing authorisation.